Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab.
Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale.
Identification of the Interaction Between the Human Homologue of the Arabidopsis COP9 Signalosome Subunit 7a and Olig1.
The Neurophysiologist Perspective into MS Plasticity.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Why does multiple sclerosis only affect human primates?
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.
Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.
Therapies for multiple sclerosis: translational achievements and outstanding needs.
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Central auditory processing and word discrimination in patients with multiple sclerosis.
Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study.
Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis.
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Physiological Role of K(+) Channels in the Regulation of T Cell Function.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
The many faces of impaired bladder emptying.
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis.
Pages
« first
‹ previous
…
565
566
567
568
569
570
571
572
573
…
next ›
last »